# US 2013/0157926 A1 · Boronated polymers

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2013/0157926 A1
- Document ID: US20130157926A1
- Status: Published application
- Kind: A1
- Application number: 13/704,960
- Filed: 2011-06-20
- Published: 2013-06-20
- Earliest claimed: 2010-06-18
- Inventors: Johannes Franciscus Joseph Engbersen; Martin Piest
- Web page: https://patentgrep.com/patent/US20130157926A1

## CPC

- A61K 47/34: Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers (A61K47/10 takes precedence)
- A61K 9/06: Ointments; Bases therefor; {Other semi-solid forms, e.g. creams, sticks, gels (composition of ointments, creams or gels A61K47/00)}
- A61K 9/5146: {obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyamines, polyanhydrides}
- C08G 65/337: containing other elements (organic compounds containing halogens only as halides of a carboxyl group C08G65/332)
- C08G 69/42: Polyamides containing atoms other than carbon, hydrogen, oxygen, and nitrogen (C08G69/12, C08G69/32 take precedence)
- C08G 69/48: Polymers modified by chemical after-treatment
- C08G 73/02: Polyamines
- C08G 73/028: {Polyamidoamines}
- C08L 79/02: Polyamines
- C08G 2650/50: containing nitrogen, e.g. polyetheramines or Jeffamines(r)
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- C08G: MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08L: COMPOSITIONS OF MACROMOLECULAR COMPOUNDS (compositions based on polymerisable monomers C08F, C08G; artificial filaments or fibres D01F; textile treating compositions D06)

## Abstract

The present invention relates to a boronated polymer according to Formula (1): a process for making the boronated polymer according to Formula (1), drug 10 delivery systems, aggregates, nanoparticles and hydrogels comprising the boronated polymer according to Formula (1).

## Claims

### Claim at position 1

1-19. (canceled)

### Claim 20

A boronated polymer according to Formula (1):
wherein:
A is independently selected from a direct carbon-carbon single bond, O, N and S;
R1 is independently selected from H and CH3;
R2 is independently selected from the group consisting of:
(a) C1-C20 alkylene, wherein the alkylene group is optionally substituted and/or is optionally (partly) unsaturated and/or is optionally interrupted by one or more heteroatoms, wherein the heteroatoms are independently selected from O, N and S, and/or wherein the alkylene group is interrupted by one or more —S—S— groups;
(b) C3-C20 cycloalkylene, wherein the cycloalkylene group is optionally substituted and/or is optionally (partly) unsaturated and/or optionally comprises one or more heteroatoms in the ring, wherein the heteroatoms are independently selected from O, N and S, and/or wherein the cycloalkylene group is interrupted by one or more —S—S-groups outside the ring;
(c) C6-C20 arylene, wherein the arylene group is optionally substituted;
(d) C6-C20 heteroarylene, wherein the heteroarylene group comprises 1-3 heteroatoms independently selected from O, N and S and/or wherein the heteroarylene group is optionally substituted;
(e) C7-C20 alkylarylene wherein the alkylarylene group is optionally substituted and/or wherein an alkyl part of the alkylarylene group is optionally (partly) unsaturated and/or is optionally interrupted by one or more heteroatoms, wherein the heteroatoms are independently selected from O, N and S, and/or wherein an alkyl part of the alkylarylene group is interrupted by one or more —S—S— groups;
(f) C7-C20 alkylheteroarylene, wherein the alkylheteroarylene group comprises 1-3 heteroatoms independently selected from O, N and S and/or wherein the alkylheteroarylene group is optionally substituted, and/or wherein an alkyl part of the alkylheteroarylene group is optionally (partly) unsaturated and/or is optionally interrupted by one or more heteroatoms, wherein the heteroatoms are independently selected from O, N and S, and/or wherein an alkyl part of the alkylheteroarylene group is interrupted by one or more —S—S— groups; and
(g) a group wherein two (hetero)arylene groups and/or alkyl(hetero)arylene groups are connected to each other by a —S—S— group;
D is selected from the group consisting of —(CR42)r- and the groups (a), (b), (c), (d), (e), (f) and (g) defined for R2;
R4 is independently selected from the group consisting of:
(a) H;
(b) C1-C20 alkyl, wherein the alkyl group is optionally substituted and/or is optionally (partly) unsaturated and/or is optionally interrupted by one or more heteroatoms, wherein the heteroatoms are independently selected from O, N and S;
(c) C3-C20 cycloalkyl, wherein the cycloalkyl group is optionally substituted and/or is optionally (partly) unsaturated and/or optionally comprises one or more heteroatoms in the ring, wherein the heteroatoms are independently selected from O, N and S;
(d) C6-C20 aryl, wherein the aryl group is optionally substituted;
(e) C6-C20 heteroaryl, wherein the heteroaryl group comprises 1-3 heteroatoms independently selected from O, N and S and/or wherein the heteroaryl group is optionally substituted;
(f) C7-C20 alkylaryl wherein the alkylaryl group is optionally substituted and/or wherein an alkyl part of the alkylarylene group is optionally (partly) unsaturated and/or is optionally interrupted by one or more heteroatoms, wherein the heteroatoms are independently selected from O, N and S; and
(g) C7-C20 alkylheteroaryl, wherein the alkylheteroaryl group comprises 1-3 heteroatoms independently selected from O, N and S and/or wherein the alkylheteroaryl group is optionally substituted, and/or wherein an alkyl part of the alkylheteroaryl group is optionally (partly) unsaturated and/or is optionally interrupted by one or more heteroatoms, wherein the heteroatoms are independently selected from O, N and S;
R5 is independently selected from the group consisting of H and C1-C20 alkyl, wherein the alkyl group is optionally substituted and/or is optionally (partly) unsaturated and/or is optionally interrupted by one or more heteroatoms, wherein the heteroatoms are independently selected from O, N and S;
p=1 to 100;
q=0 to 100;
r=2-6;
s=0-5;
R3 has the Formula (2):
wherein:
a is 1 or 2;
R6 is independently selected from
(a) H;
(b) C1-C12 alkyl, wherein the alkyl group is optionally substituted and/or is optionally (partly) unsaturated and/or is optionally interrupted by one or more heteroatoms, wherein the heteroatoms are independently selected from O, N and S;
(c) C3-C12 cycloalkyl, wherein the cycloalkyl group is optionally substituted and/or is optionally (partly) unsaturated and/or is optionally interrupted by one or more heteroatoms, wherein the heteroatoms are independently selected from O, N and S;
(d) C6-C20 aryl, wherein the aryl group is optionally substituted;
(e) C6-C20 heteroaryl, wherein the heteroaryl group comprises 1-3 heteroatoms independently selected from O, N and S and/or wherein the heteroarylene group is optionally substituted;
(f) C7-C20 alkylaryl wherein the alkylaryl group is optionally substituted and/or wherein an alkyl part of the alkylaryle group is optionally (partly) unsaturated and/or is optionally interrupted by one or more heteroatoms, wherein the heteroatoms are independently selected from O, N and S; and
(g) C7-C20 alkylheteroarylene, wherein the alkylheteroarylene group comprises 1-3 heteroatoms independently selected from O, N and S and/or wherein the alkylheteroarylene group is optionally substituted, and/or wherein an alkyl part of the alkylheteroarylene group is optionally (partly) unsaturated and/or is optionally interrupted by one or more heteroatoms, wherein the heteroatoms are independently selected from O, N and S;
R7 is independently selected from
(a) halogen;
(b) C1-C12 alkyl, wherein the alkyl group is optionally substituted and/or is optionally (partly) unsaturated and/or is optionally interrupted by one or more heteroatoms, wherein the heteroatoms are independently selected from O, N and S;
(c) C3-C12 cycloalkyl, wherein the cycloalkyl group is optionally substituted and/or is optionally (partly) unsaturated and/or is optionally interrupted by one or more heteroatoms, wherein the heteroatoms are independently selected from O, N and S;
(d) C6-C20 aryl, wherein the aryl group is optionally substituted;
(e) C6-C20 heteroaryl, wherein the heteroaryl group comprises 1-3 heteroatoms independently selected from O, N and S and/or wherein the heteroarylene group is optionally substituted;
(f) C7-C20 alkylaryl wherein the alkylaryl group is optionally substituted and/or wherein an alkyl part of the alkylaryl group is optionally (partly) unsaturated and/or is optionally interrupted by one or more heteroatoms, wherein the heteroatoms are independently selected from O, N and S; and
(g) C7-C20 alkylheteroarylene, wherein the alkylheteroarylene group comprises 1-3 heteroatoms independently selected from O, N and S and/or wherein the alkylheteroarylene group is optionally substituted, and/or wherein an alkyl part of the alkylheteroarylene group is optionally (partly) unsaturated and/or is optionally interrupted by one or more heteroatoms, wherein the heteroatoms are independently selected from O, N and S;
E is independently selected from the group consisting of:
—(CR82)u—N(R9)—C(O)—,
—C(O)—N(R9)—(CR82)u—,
—(CR82)u—N═CR9—,
—CR9═N—(CR82)u—, and
—(CR82)u—N(R9)—(CR82)v—;
t=0-4;
u=1-10;
v=1-4;
R8 is independently selected from the group consisting of H and C1-C20 alkyl;
R9 is independently selected from the group consisting of H and C1-C20 alkyl; and
when s=0, then R3* is independently selected from the group consisting of
(a) H,
(b) C1-C12 alkyl, wherein the alkyl group is optionally substituted and/or is optionally (partly) unsaturated and/or is optionally interrupted by one or more heteroatoms, wherein the heteroatoms are independently selected from O, N and S;
(c) C3-C12 cycloalkyl, wherein the cycloalkyl group is optionally substituted and/or is optionally (partly) unsaturated and/or is optionally interrupted by one or more heteroatoms, wherein the heteroatoms are independently selected from O, N and S;
(d) C6-C20 aryl, wherein the aryl group is optionally substituted;
(e) C6-C20 heteroaryl, wherein the heteroaryl group comprises 1-3 heteroatoms independently selected from O, N and S and/or wherein the heteroarylene group is optionally substituted;
(f) C7-C20 alkylaryl wherein the alkylaryl group is optionally substituted and/or wherein an alkyl part of the alkylaryl group is optionally (partly) unsaturated and/or is optionally interrupted by one or more heteroatoms, wherein the heteroatoms are independently selected from O, N and S; and
(g) C7-C20 alkylheteroaryl, wherein the alkylheteroaryl group comprises 1-3 heteroatoms independently selected from O, N and S and/or wherein the alkylheteroaryl group is optionally substituted, and/or wherein an alkyl part of the alkylheteroaryl group is optionally (partly) unsaturated and/or is optionally interrupted by one or more heteroatoms, wherein the heteroatoms are independently selected from O, N and S;
when s=1-5, then R3* is independently selected from the group consisting of
(a) H;
(b) C1-C6 alkyl, wherein the alkyl group is optionally substituted;
(c) C3-C6 cycloalkyl, wherein the cycloalkyl group is optionally substituted; C6-C12 aryl, wherein the aryl group is optionally substituted;
(d) C6-C12 heteroaryl, wherein the heteroaryl group comprises 1-3 heteroatoms independently selected from O, N and S and/or wherein the heteroarylene group is optionally substituted;
(e) C7-C12 alkylaryl wherein the alkylaryl group is optionally substituted; and
(f) C7-C12 alkylheteroaryl, wherein the alkylheteroaryl group comprises 1-3 heteroatoms independently selected from O, N and S and/or wherein the alkylheteroaryl group is optionally substituted.

### Claim 21 (depends on 20)

The boronated polymer according to claim 20, wherein the boronated polymer has a number average molecular weight Mn in the range of about 1,000 to about 100,000.

### Claim 22 (depends on 20)

The boronated polymer according to claim 20, wherein s is 0.

### Claim 23 (depends on 20)

The boronated polymer according to claim 20, wherein q is 0.

### Claim 24 (depends on 20)

The boronated polymer according to claim 20, wherein v is 1 or 2.

### Claim 25 (depends on 20)

The boronated polymer according to claim 20, wherein a is 1.

### Claim 26 (depends on 20)

The boronated polymer according to claim 20, wherein t is 0, 1 or 2.

### Claim 27

A process for preparing a boronated polymer according to Formula (1):
wherein:
A is independently selected from a direct carbon-carbon single bond, O, N and S;
R1 is independently selected from H and CH3;
R2 is independently selected from the group consisting of:
(a) C1-C20 alkylene, wherein the alkylene group is optionally substituted and/or is optionally (partly) unsaturated and/or is optionally interrupted by one or more heteroatoms, wherein the heteroatoms are independently selected from O, N and S, and/or wherein the alkylene group is interrupted by one or more —S—S— groups;
(b) C3-C20 cycloalkylene, wherein the cycloalkylene group is optionally substituted and/or is optionally (partly) unsaturated and/or optionally comprises one or more heteroatoms in the ring, wherein the heteroatoms are independently selected from O, N and S, and/or wherein the cycloalkylene group is interrupted by one or more —S—S-groups outside the ring;
(c) C6-C20 arylene, wherein the arylene group is optionally substituted;
(d) C6-C20 heteroarylene, wherein the heteroarylene group comprises 1-3 heteroatoms independently selected from O, N and S and/or wherein the heteroarylene group is optionally substituted;
(e) C7-C20 alkylarylene wherein the alkylarylene group is optionally substituted and/or wherein an alkyl part of the alkylarylene group is optionally (partly) unsaturated and/or is optionally interrupted by one or more heteroatoms, wherein the heteroatoms are independently selected from O, N and S, and/or wherein an alkyl part of the alkylarylene group is interrupted by one or more —S—S— groups;
(f) C7-C20 alkylheteroarylene, wherein the alkylheteroarylene group comprises 1-3 heteroatoms independently selected from O, N and S and/or wherein the alkylheteroarylene group is optionally substituted, and/or wherein an alkyl part of the alkylheteroarylene group is optionally (partly) unsaturated and/or is optionally interrupted by one or more heteroatoms, wherein the heteroatoms are independently selected from O, N and S, and/or wherein an alkyl part of the alkylheteroarylene group is interrupted by one or more —S—S— groups; and
(g) a group wherein two (hetero)arylene groups and/or alkyl(hetero)arylene groups are connected to each other by a —S—S— group;
D is selected from the group consisting of —(CR42)r- and the groups (a), (b), (c), (d), (e), (f) and (g) defined for R2;
R4 is independently selected from the group consisting of:
(h) H;
(i) C1-C20 alkyl, wherein the alkyl group is optionally substituted and/or is optionally (partly) unsaturated and/or is optionally interrupted by one or more heteroatoms, wherein the heteroatoms are independently selected from O, N and S;
(j) C3-C20 cycloalkyl, wherein the cycloalkyl group is optionally substituted and/or is optionally (partly) unsaturated and/or optionally comprises one or more heteroatoms in the ring, wherein the heteroatoms are independently selected from O, N and S;
(k) C6-C20 aryl, wherein the aryl group is optionally substituted;
(l) C6-C20 heteroaryl, wherein the heteroaryl group comprises 1-3 heteroatoms independently selected from O, N and S and/or wherein the heteroaryl group is optionally substituted;
(m) C7-C20 alkylaryl wherein the alkylaryl group is optionally substituted and/or wherein an alkyl part of the alkylarylene group is optionally (partly) unsaturated and/or is optionally interrupted by one or more heteroatoms, wherein the heteroatoms are independently selected from O, N and S; and
(n) C7-C20 alkylheteroaryl, wherein the alkylheteroaryl group comprises 1-3 heteroatoms independently selected from O, N and S and/or wherein the alkylheteroaryl group is optionally substituted, and/or wherein an alkyl part of the alkylheteroaryl group is optionally (partly) unsaturated and/or is optionally interrupted by one or more heteroatoms, wherein the heteroatoms are independently selected from O, N and S;
R3 is independently selected from the group consisting of H and C1-C20 alkyl, wherein the alkyl group is optionally substituted and/or is optionally (partly) unsaturated and/or is optionally interrupted by one or more heteroatoms, wherein the heteroatoms are independently selected from O, N and S;
p=1 to 100;
q=0 to 100;
r=2-6;
s=0-5;
R3 has the Formula (2):
wherein:
a is 1 or 2;
R6 is independently selected from
(h) H;
(i) C1-C12 alkyl, wherein the alkyl group is optionally substituted and/or is optionally (partly) unsaturated and/or is optionally interrupted by one or more heteroatoms, wherein the heteroatoms are independently selected from O, N and S;
(j) C3-C12 cycloalkyl, wherein the cycloalkyl group is optionally substituted and/or is optionally (partly) unsaturated and/or is optionally interrupted by one or more heteroatoms, wherein the heteroatoms are independently selected from O, N and S;
(k) C6-C20 aryl, wherein the aryl group is optionally substituted;
(l) C6-C20 heteroaryl, wherein the heteroaryl group comprises 1-3 heteroatoms independently selected from O, N and S and/or wherein the heteroarylene group is optionally substituted;
(m) C7-C20 alkylaryl wherein the alkylaryl group is optionally substituted and/or wherein an alkyl part of the alkylaryle group is optionally (partly) unsaturated and/or is optionally interrupted by one or more heteroatoms, wherein the heteroatoms are independently selected from O, N and S; and
(n) C7-C20 alkylheteroarylene, wherein the alkylheteroarylene group comprises 1-3 heteroatoms independently selected from O, N and S and/or wherein the alkylheteroarylene group is optionally substituted, and/or wherein an alkyl part of the alkylheteroarylene group is optionally (partly) unsaturated and/or is optionally interrupted by one or more heteroatoms, wherein the heteroatoms are independently selected from O, N and S;
R7 is independently selected from
(h) halogen;
(i) C1-C12 alkyl, wherein the alkyl group is optionally substituted and/or is optionally (partly) unsaturated and/or is optionally interrupted by one or more heteroatoms, wherein the heteroatoms are independently selected from O, N and S;
(j) C3-C12 cycloalkyl, wherein the cycloalkyl group is optionally substituted and/or is optionally (partly) unsaturated and/or is optionally interrupted by one or more heteroatoms, wherein the heteroatoms are independently selected from O, N and S;
(k) C6-C20 aryl, wherein the aryl group is optionally substituted;
(l) C6-C20 heteroaryl, wherein the heteroaryl group comprises 1-3 heteroatoms independently selected from O, N and S and/or wherein the heteroarylene group is optionally substituted;
(m) C7-C20 alkylaryl wherein the alkylaryl group is optionally substituted and/or wherein an alkyl part of the alkylaryl group is optionally (partly) unsaturated and/or is optionally interrupted by one or more heteroatoms, wherein the heteroatoms are independently selected from O, N and S; and
(n) C7-C20 alkylheteroarylene, wherein the alkylheteroarylene group comprises 1-3 heteroatoms independently selected from O, N and S and/or wherein the alkylheteroarylene group is optionally substituted, and/or wherein an alkyl part of the alkylheteroarylene group is optionally (partly) unsaturated and/or is optionally interrupted by one or more heteroatoms, wherein the heteroatoms are independently selected from O, N and S;
E is independently selected from the group consisting of:
—(CR82)u—N(R9)—C(O)—,
—C(O)—N(R9)—(CR82)u—,
—(CR82)u—N═CR9—,
—CR9═N—(CR8u)u—, and
—(CR82)u—N(R9)—(CR82)v—;
t=0-4;
u=1-10;
v=1-4;
R8 is independently selected from the group consisting of H and C1-C20 alkyl;
R9 is independently selected from the group consisting of H and C1-C20 alkyl; and
when s=0, then R3* is independently selected from the group consisting of
(h) H,
(i) C1-C12 alkyl, wherein the alkyl group is optionally substituted and/or is optionally (partly) unsaturated and/or is optionally interrupted by one or more heteroatoms, wherein the heteroatoms are independently selected from O, N and S;
(j) C3-C12 cycloalkyl, wherein the cycloalkyl group is optionally substituted and/or is optionally (partly) unsaturated and/or is optionally interrupted by one or more heteroatoms, wherein the heteroatoms are independently selected from O, N and S;
(k) C6-C20 aryl, wherein the aryl group is optionally substituted;
(l) C6-C20 heteroaryl, wherein the heteroaryl group comprises 1-3 heteroatoms independently selected from O, N and S and/or wherein the heteroarylene group is optionally substituted;
(m) C7-C20 alkylaryl wherein the alkylaryl group is optionally substituted and/or wherein an alkyl part of the alkylaryl group is optionally (partly) unsaturated and/or is optionally interrupted by one or more heteroatoms, wherein the heteroatoms are independently selected from O, N and S; and
(n) C7-C20 alkylheteroaryl, wherein the alkylheteroaryl group comprises 1-3 heteroatoms independently selected from O, N and S and/or wherein the alkylheteroaryl group is optionally substituted, and/or wherein an alkyl part of the alkylheteroaryl group is optionally (partly) unsaturated and/or is optionally interrupted by one or more heteroatoms, wherein the heteroatoms are independently selected from O, N and S;
when s=1-5, then R3* is independently selected from the group consisting of
(g) H;
(h) C1-C6 alkyl, wherein the alkyl group is optionally substituted;
(i) C3-C6 cycloalkyl, wherein the cycloalkyl group is optionally substituted; C6-C12 aryl, wherein the aryl group is optionally substituted;
(j) C6-C12 heteroaryl, wherein the heteroaryl group comprises 1-3 heteroatoms independently selected from O, N and S and/or wherein the heteroarylene group is optionally substituted;
(k) C7-C12 alkylaryl wherein the alkylaryl group is optionally substituted; and
(l) C7-C12 alkylheteroaryl, wherein the alkylheteroaryl group comprises 1-3 heteroatoms independently selected from O, N and S and/or wherein the alkylheteroaryl group is optionally substituted;
said process comprising polymerizing a monomer according to Formula (6):
with a monomer according to Formula (7):
H2N—R3 (7).

### Claim 28 (depends on 27)

The process according to claim 27, wherein said boronated polymer is according to Formula (3):
and wherein said process is performed in the presence of a monomer according to Formula (8):
H2N—R3* (8).

### Claim 29 (depends on 27)

The process according to claim 27, wherein said process is performed in the presence of a monomer according to Formula (9):

### Claim 30 (depends on 27)

A process according to claim 27, wherein q is 0, said process comprising:
(a) polymerizing a monomer according to Formula (6):
with a monomer according to Formula (10):
tBuO—C(O)—N(H)—(CR82)w—NH2 (10)
wherein w=2-20 and R8 is independently selected from the group consisting of H and C1-C20 alkyl, to obtain a polymer according to Formula (11):
wherein R10 is tBuO—C(O)—N(H)—(CR82)—NH—;
(b) reacting the polymer according to Formula (11) with an acid to obtain a formula according to Formula (11) wherein R10 is H2N—(CR82)—NH—; and
(c) reacting the polymer as obtained in step (b) with a compound according to Formula (12):
wherein:
a is 1 or 2;
R6 is independently selected from
(a) H;
(b) C1-C12 alkyl, wherein the alkyl group is optionally substituted and/or is optionally (partly) unsaturated and/or is optionally interrupted by one or more heteroatoms, wherein the heteroatoms are independently selected from O, N and S;
(c) C3-C12 cycloalkyl, wherein the cycloalkyl group is optionally substituted and/or is optionally (partly) unsaturated and/or is optionally interrupted by one or more heteroatoms, wherein the heteroatoms are independently selected from O, N and S;
(d) C6-C20 aryl, wherein the aryl group is optionally substituted;
(e) C6-C20 heteroaryl, wherein the heteroaryl group comprises 1-3 heteroatoms independently selected from O, N and S and/or wherein the heteroarylene group is optionally substituted;
(f) C7-C20 alkylaryl wherein the alkylaryl group is optionally substituted and/or wherein an alkyl part of the alkylaryle group is optionally (partly) unsaturated and/or is optionally interrupted by one or more heteroatoms, wherein the heteroatoms are independently selected from O, N and S; and
(g) C7-C20 alkylheteroarylene, wherein the alkylheteroarylene group comprises 1-3 heteroatoms independently selected from O, N and S and/or wherein the alkylheteroarylene group is optionally substituted, and/or wherein an alkyl part of the alkylheteroarylene group is optionally (partly) unsaturated and/or is optionally interrupted by one or more heteroatoms, wherein the heteroatoms are independently selected from O, N and S;
R7 is independently selected from
(a) halogen;
(b) C1-C12 alkyl, wherein the alkyl group is optionally substituted and/or is optionally (partly) unsaturated and/or is optionally interrupted by one or more heteroatoms, wherein the heteroatoms are independently selected from O, N and S;
(c) C3-C12 cycloalkyl, wherein the cycloalkyl group is optionally substituted and/or is optionally (partly) unsaturated and/or is optionally interrupted by one or more heteroatoms, wherein the heteroatoms are independently selected from O, N and S;
(d) C6-C20 aryl, wherein the aryl group is optionally substituted;
(e) C6-C20 heteroaryl, wherein the heteroaryl group comprises 13 heteroatoms independently selected from O, N and S and/or wherein the heteroarylene group is optionally substituted;
(f) C7-C20 alkylaryl wherein the alkylaryl group is optionally substituted and/or wherein an alkyl part of the alkylaryle group is optionally (partly) unsaturated and/or is optionally interrupted by one or more heteroatoms, wherein the heteroatoms are independently selected from O, N and S; and
(g) C7-C20 alkylheteroarylene, wherein the alkylheteroarylene group comprises 1-3 heteroatoms independently selected from O, N and S and/or wherein the alkylheteroarylene group is optionally substituted, and/or wherein an alkyl part of the alkylheteroarylene group is optionally (partly) unsaturated and/or is optionally interrupted by one or more heteroatoms, wherein the heteroatoms are independently selected from O, N and S.

### Claim 31 (depends on 30)

The process according to claim 30, wherein any pendant amino groups are subjected to acylation.

### Claim 32 (depends on 20)

A drug delivery system comprising the boronated polymer according to claim 20.

### Claim 33 (depends on 32)

The drug delivery system according to claim 32, wherein the aggregate comprises a biologically active component.

### Claim 34 (depends on 33)

The drug delivery system according to claim 33, wherein the biologically active component is selected from the group consisting of drugs, anionic polymers, DNA molecules and derivatives thereof, RNA molecules and derivatives thereof, peptides and derivatives thereof, and proteins and derivatives thereof.

### Claim 35 (depends on 32)

The drug delivery system according to claim 32, wherein R2 is independently selected from the group consisting of:
(a) C1-C20 alkylene, wherein the alkylene group is optionally substituted and is interrupted by one or more —S—S— groups; and
(b) C3-C20 cycloalkylene, wherein the cycloalkylene group is optionally substituted and is interrupted by one or more —S—S— groups outside the ring.

### Claim 36 (depends on 33)

The drug delivery system according to claim 33, wherein R2 is independently selected from the group consisting of:
(a) C1-C20 alkylene, wherein the alkylene group is optionally substituted and is interrupted by one or more —S—S— groups; and
(b) C3-C20 cycloalkylene, wherein the cycloalkylene group is optionally substituted and is interrupted by one or more —S—S— groups outside the ring.

### Claim 37 (depends on 34)

The drug delivery system according to claim 34, wherein R2 is independently selected from the group consisting of:
(a) C1-C20 alkylene, wherein the alkylene group is optionally substituted and is interrupted by one or more —S—S— groups; and
(b) C3-C20 cycloalkylene, wherein the cycloalkylene group is optionally substituted and is interrupted by one or more —S—S— groups outside the ring.

### Claim 38 (depends on 32)

The drug delivery system according to claim 32, wherein the drug delivery system comprises an aggregate.

### Claim 39 (depends on 32)

The drug delivery system according to claim 32, wherein the drug delivery system comprises a nanoparticle.

### Claim 40 (depends on 32)

The drug delivery system according to claim 32, wherein the drug delivery system comprises a hydrogel.

### Claim 41 (depends on 20)

A hydrogel comprising the boronated polymer according to claim 20.

### Claim 42 (depends on 41)

The hydrogel according to claim 41, further comprising a polyvinyl alcohol, a carbohydrate, or a crosslinker.

### Claim 43

A hydrogel comprising a poly(boronic acid) cross-linker according to Formula (14):
wherein:
a=1 or 2;
R6 is independently selected from
(a) H;
(b) C1-C12 alkyl, wherein the alkyl group is optionally substituted and/or is optionally (partly) unsaturated and/or is optionally interrupted by one or more heteroatoms, wherein the heteroatoms are independently selected from O, N and S;
(c) C3-C12 cycloalkyl, wherein the cycloalkyl group is optionally substituted and/or is optionally (partly) unsaturated and/or is optionally interrupted by one or more heteroatoms, wherein the heteroatoms are independently selected from O, N and S; C6-C20 aryl, wherein the aryl group is optionally substituted;
(d) C6-C20 heteroaryl, wherein the heteroaryl group comprises 1-3 heteroatoms independently selected from O, N and S and/or wherein the heteroarylene group is optionally substituted;
(e) C7-C20 alkylaryl wherein the alkylaryl group is optionally substituted and/or wherein an alkyl part of the alkylaryl group is optionally (partly) unsaturated and/or is optionally interrupted by one or more heteroatoms, wherein the heteroatoms are independently selected from O, N and S; and
(f) C7-C20 alkylheteroarylene, wherein the alkylheteroarylene group comprises 1-3 heteroatoms independently selected from O, N and S and/or wherein the alkylheteroarylene group is optionally substituted, and/or wherein an alkyl part of the alkylheteroarylene group is optionally (partly) unsaturated and/or is optionally interrupted by one or more heteroatoms, wherein the heteroatoms are independently selected from O, N and S;
R7 is independently selected from
(g) halogen;
(h) C1-C12 alkyl, wherein the alkyl group is optionally substituted and/or is optionally (partly) unsaturated and/or is optionally interrupted by one or more heteroatoms, wherein the heteroatoms are independently selected from O, N and S;
(i) C3-C12 cycloalkyl, wherein the cycloalkyl group is optionally substituted and/or is optionally (partly) unsaturated and/or is optionally interrupted by one or more heteroatoms, wherein the heteroatoms are independently selected from O, N and S;
(j) C6-C20 aryl, wherein the aryl group is optionally substituted;
(k) C6-C20 heteroaryl, wherein the heteroaryl group comprises 1-3 heteroatoms independently selected from O, N and S and/or wherein the heteroarylene group is optionally substituted;
(l) C7-C20 alkylaryl wherein the alkylaryl group is optionally substituted and/or wherein an alkyl part of the alkylaryl group is optionally (partly) unsaturated and/or is optionally interrupted by one or more heteroatoms, wherein the heteroatoms are independently selected from O, N and S; and
(m) C7-C20 alkylheteroarylene, wherein the alkylheteroarylene group comprises 1-3 heteroatoms independently selected from O, N and S and/or wherein the alkylheteroarylene group is optionally substituted, and/or wherein an alkyl part of the alkylheteroarylene group is optionally (partly) unsaturated and/or is optionally interrupted by one or more heteroatoms, wherein the heteroatoms are independently selected from O, N and S;
E is independently selected from the group consisting of:
—(CR82)u—N(R9)—C(O)—,
—C(O)—N(R9)—(CR82)u—,
—(CR82)u—N═CR9—,
—C(R9)═N—(CR82)u—, and
—(CR82)u—N(R9)—(CR82)v—;
R8 is independently selected from the group consisting of H and C1-C20 alkyl;
R9 is independently selected from the group consisting of H and C1-C20 alkyl;
t=0-4;
u=1-10;
v=1-4;
R12 is independently selected from
(a) C1-C12 alkylene, wherein the alkylene group is optionally substituted and/or is optionally (partly) unsaturated and/or is optionally interrupted by one or more heteroatoms, wherein the heteroatoms are independently selected from O, N and S;
(b) C3-C12 cycloalkylene, wherein the cycloalkylene group is optionally substituted and/or is optionally (partly) unsaturated and/or is optionally interrupted by one or more heteroatoms, wherein the heteroatoms are independently selected from O, N and S;
(c) C6-C20 arylene, wherein the arylene group is optionally substituted;
(d) C6-C20 heteroarylene, wherein the heteroarylene group comprises 1-3 heteroatoms independently selected from O, N and S and/or wherein the heteroarylene group is optionally substituted;
(e) C7-C20 alkylarylene wherein the alkylarylene group is optionally substituted and/or wherein an alkyl part of the alkylarylene group is optionally (partly) unsaturated and/or is optionally interrupted by one or more heteroatoms, wherein the heteroatoms are independently selected from O, N and S; and
(f) C7-C20 alkylheteroarylene, wherein the alkylheteroarylene group is optionally substituted, and/or wherein an alkyl part of the alkylheteroarylene group is optionally (partly) unsaturated and/or is optionally interrupted by one or more heteroatoms, wherein the heteroatoms are independently selected from O, N and S;
(g) Polyalkylene having a weight average molecular weight Mw of about 150 to about 10,000, wherein the polyalkylene group may be linear or branched and is interrupted by one or more heteroatoms, wherein the heteroatoms are independently selected from O, N and S.

### Claim 44

A hydrogel comprising a poly(boronic acid) cross-linker according to Formula (15):
wherein:
x=3-8;
a=1 or 2;
R6 is independently selected from
(g) H;
(h) C1-C12 alkyl, wherein the alkyl group is optionally substituted and/or is optionally (partly) unsaturated and/or is optionally interrupted by one or more heteroatoms, wherein the heteroatoms are independently selected from O, N and S;
(i) C3-C12 cycloalkyl, wherein the cycloalkyl group is optionally substituted and/or is optionally (partly) unsaturated and/or is optionally interrupted by one or more heteroatoms, wherein the heteroatoms are independently selected from O, N and S; C6-C20 aryl, wherein the aryl group is optionally substituted;
(j) C6-C20 heteroaryl, wherein the heteroaryl group comprises 1-3 heteroatoms independently selected from O, N and S and/or wherein the heteroarylene group is optionally substituted;
(k) C7-C20 alkylaryl wherein the alkylaryl group is optionally substituted and/or wherein an alkyl part of the alkylaryl group is optionally (partly) unsaturated and/or is optionally interrupted by one or more heteroatoms, wherein the heteroatoms are independently selected from O, N and S; and
(l) C7-C20 alkylheteroarylene, wherein the alkylheteroarylene group comprises 1-3 heteroatoms independently selected from O, N and S and/or wherein the alkylheteroarylene group is optionally substituted, and/or wherein an alkyl part of the alkylheteroarylene group is optionally (partly) unsaturated and/or is optionally interrupted by one or more heteroatoms, wherein the heteroatoms are independently selected from O, N and S;
R7 is independently selected from
(n) halogen;
(o) C1-C12 alkyl, wherein the alkyl group is optionally substituted and/or is optionally (partly) unsaturated and/or is optionally interrupted by one or more heteroatoms, wherein the heteroatoms are independently selected from O, N and S;
(p) C3-C12 cycloalkyl, wherein the cycloalkyl group is optionally substituted and/or is optionally (partly) unsaturated and/or is optionally interrupted by one or more heteroatoms, wherein the heteroatoms are independently selected from O, N and S;
(q) C6-C20 aryl, wherein the aryl group is optionally substituted;
(r) C6-C20 heteroaryl, wherein the heteroaryl group comprises 1-3 heteroatoms independently selected from O, N and S and/or wherein the heteroarylene group is optionally substituted;
(s) C7-C20 alkylaryl wherein the alkylaryl group is optionally substituted and/or wherein an alkyl part of the alkylaryl group is optionally (partly) unsaturated and/or is optionally interrupted by one or more heteroatoms, wherein the heteroatoms are independently selected from O, N and S; and
(t) C7-C20 alkylheteroarylene, wherein the alkylheteroarylene group comprises 1-3 heteroatoms independently selected from O, N and S and/or wherein the alkylheteroarylene group is optionally substituted, and/or wherein an alkyl part of the alkylheteroarylene group is optionally (partly) unsaturated and/or is optionally interrupted by one or more heteroatoms, wherein the heteroatoms are independently selected from O, N and S;
E is independently selected from the group consisting of:
—(CR82)u—N(R9)—C(O)—,
—C(O)—N(R9)—(CR82)u—,
—(CR82)u—N═CR9—,
—C(R9)═N—(CR82)u—, and
—(CR82)u—N(R9)—(CR82)v—;
R8 is independently selected from the group consisting of H and C1-C20 alkyl;
R9 is independently selected from the group consisting of H and C1-C20 alkyl;
t=0-4;
u=1-10;
v=1-4;
R12 is a polyalkylene having a weight average molecular weight Mw of about 1,000 to about 50,000, wherein the polyoxyalkylene has a (hyper)branched, multi-arm and/or dendrimeric structure and is interrupted by one or more heteroatoms, wherein the heteroatoms are independently selected from O, N and S.
